… the risk of developing anogenital warts, although those with higher CD4 cell counts and
lower HIV RNA levels had a lower risk of developing anogenital warts [13]. Warts are normally …

… The outcome of this study was the incidence of anogenital warts starting 3 months after the
last dose of the quadrivalent HPV vaccine. The claims with anogenital wart diagnosis were …

… of new clients with genital warts at different anatomical sites in heterosexuals compared
to MSM. The aim of this study is to describe the ratio of anogenital warts between different …

… cutaneous warts in infected skin [3,4,5]. Additionally, HPV 6 and 11, which are linked to the
development of anogenital warts (… [1,7] In detail, in active warts, the virally induced increase in …

… Historically, genital warts were believed to be cutaneous … By inoculating and injecting wart
extracts into previously … genital warts to be benign cellular proliferations of the anogenital skin …

… [1] Low Risk (LR) HPV types 6 and 11 are the predominant causes of anogenital warts (AGW),
a source of psychosocial distress,[2] and physical discomfort (including bleeding and …

… Accordingly, all women with anogenital warts should have a speculum examination to
identify the presence of coexisting vaginal and/or cervical warts. In contrast to vulvar lesions, …

… More than 90% of anogenital warts are caused by HPV type 6 and 11 [13, 28]. In women,
external anogenital warts are always accompanied by flat or exophytic warts of the vagina and …

… By also taking into consideration that the bivalent vaccine gives direct protection only against
HPV16/18, and not against HPV6/11, that cause most of the anogenital warts, we assumed …

… present anogenital warts, while as many as 5 –20% are infected with HPV [4] . Genital wart
… Systematic review and meta-analysis may be especially useful in this condition. Thus, we …